
Matej Mikulic
Research expert covering health, pharma & medtech

Detailed statistics
Pharmaceutical spending per capita in selected countries 2024

Detailed statistics
Price comparison of most expensive drugs U.S. 2025

Detailed statistics
U.S. drug prices at retail level compared to select countries by multiplier 2020

U.S. net medicine spending 2015-2030
Net spending on medicines in the U.S. from 2015 to 2030 (in billion U.S. dollars)

U.S. brand and generic prescription drug spending 2020-2023
Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023

Price comparison of most expensive drugs U.S. 2025
Most expensive drugs in the United States as of 2025 (in million U.S. dollars)

U.S. consumer price index: prescription and nonprescription drugs 1960-2025
Consumer price index for prescription and nonprescription drugs in the U.S. from 1960 to 2025

Pharmaceutical spending per capita in selected countries 2024
Pharmaceutical spending per capita in selected countries as of 2024 (in U.S. dollars)

Distribution of Rx drug dollar spending among supply chain participants U.S. 2023
Share of Rx drug dollar spending by drug supply chain participants in the U.S. in 2023

U.S. Prescription drug prices as percentage of OECD prices 2022
Prices of U.S. prescription drugs as a percentage of prices in select OECD countries as of 2022

U.S. Prescription of brand drug prices as percentage of OECD prices 2022
Prices of U.S. brand prescription drugs as a percentage of prices in select OECD countries as of 2022

U.S. generic Rx drug prices as percentage of OECD prices 2022
Prices of U.S. unbranded generic prescription drugs as a percentage of prices in select OECD countries as of 2022

Price disparities for top product Januvia U.S. vs international 2026
Price disparities for the top pharmaceutical product Januvia in the U.S. and abroad as of May 2026 (in U.S. dollars)

Price disparities for Spiriva Handihaler - U.S. and international 2026
Price disparities for Spiriva Handihaler in the U.S. and abroad as of May 2026 (in U.S. dollars)

Price disparities for top product Viagra - U.S. and international 2025
Price disparities for top pharmaceutical product Viagra in the U.S. and abroad as of July 2025 (in U.S. dollars)

Price disparities for top product Xarelto - U.S. and international 2025
Price disparities for pharmaceutical product Xarelto in the U.S. and abroad as of July 2025 (in U.S. dollars)

Price disparities for top product Symbicort - U.S. and international 2024
Price disparities for top pharmaceutical product Symbicort in the U.S. and abroad as of June 2024 (in U.S. dollars)

Price increase of top-selling drugs U.S. since launch to 2025
Price increase of select top-selling drugs in the United States between the launch of the drug and 2025

Change in U.S. list and net drug prices 2024 by manufacturer
Change in list and net pharmaceutical product prices in the U.S. in 2024, by manufacturer

Medicare spending per beneficiary on major drugs in the U.S. 2024
Medicare spending per beneficiary on select major drugs in the United States in 2024

Annual Medicare spending growth of top U.S. drugs 2019-2023
Annual Medicare spending growth rate of select top-selling drugs in the United States between 2019 and 2023

Comparison WAC of Herceptin vs biosimilars in the U.S. Q1 2026
Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars)

Comparison of ASP Herceptin vs biosimilars in the U.S. Q1 2026
Comparison of the average sales price (ASP) of Herceptin vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars)

Comparison of WAC of Remicade vs biosimilars in the U.S. as of Q1 2026
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars)

Comparison ASP of Remicade vs biosimilars in the U.S. Q1 2026
Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars)

Share of adults in the U.S. who take one or more prescription medicines 2026
Percentage of adults in the United States who take one or more prescription medicines as of 2026

Perception of adults on cost of prescription drugs U.S. 2023
Perception of adults in the United States on the cost of prescription drugs as of 2023

Share of U.S. adults who have not taken their medicine as prescribed due to cost 2026
Percentage of adults in the United States who have not taken their medicine as prescribed due to costs as of 2026

Contributing factor to prescription drug costs according to U.S. adults 2026
Major contributing factors to prescription drug costs according to U.S. adults as of 2026, by political affiliation

U.S. adults having difficulty affording their Rx medicine by characteristic 2026
Percentage of U.S. adults who have difficulty affording their prescription medicine as of 2026, by characteristic
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.